Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

1. Fenix-Caballero, S.
2. Sanchez-Vegas, A.
3. Alegre Del-Rey, E.J.
4. Epstein, D.
5. Garcia-Mochon, L.
6. Olry de Labry Lima, A.